India Resurgence’s Acquisition of API and CRAMS Business of Ind Swift Laboratories

Maha Kanaan
Tagged:

Khaitan & Co advised India Resurgence Fund on the deal.India Resurgence Fund completed the acquisition of active pharmaceutical ingredients (API) and contract research and manufacturing services (CRAMS)…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Maha Kanaan

Author: Maha Kanaan

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here